| Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway R Singh, S Chandrashekharappa, SR Bodduluri, BV Baby, B Hegde, ... Nature communications 10 (1), 1-18, 2019 | 486 | 2019 |
| Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth SR Satpathy, VR Jala, SR Bodduluri, E Krishnan, B Hegde, GW Hoyle, ... Nature communications 6 (1), 7064, 2015 | 104 | 2015 |
| RASA2 ablation in T cells boosts antigen sensitivity and long-term function J Carnevale, E Shifrut, N Kale, WA Nyberg, F Blaeschke, YY Chen, Z Li, ... Nature 609 (7925), 174-182, 2022 | 70 | 2022 |
| Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy P Chuntova, KM Downey, B Hegde, ND Almeida, H Okada Frontiers in Immunology 9, 3062, 2019 | 62 | 2019 |
| Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun 10: 89 R Singh, S Chandrashekharappa, SR Bodduluri, BV Baby, B Hegde, ... | 34 | 2019 |
| Inflammasome-Independent Leukotriene B4 Production Drives Crystalline Silica–Induced Sterile Inflammation B Hegde, SR Bodduluri, SR Satpathy, RS Alghsham, VR Jala, SM Uriarte, ... The Journal of Immunology 200 (10), 3556-3567, 2018 | 29 | 2018 |
| NF-κB dependent anti-inflammatory activity of chlorojanerin isolated from Saussurea heteromalla A Saklani, B Hegde, P Mishra, R Singh, M Mendon, D Chakrabarty, ... Phytomedicine 19 (11), 988-997, 2012 | 20 | 2012 |
| Zinc Oxide Nanowires Exposure Induces a Distinct Inflammatory Response via CCL11-Mediated Eosinophil Recruitment MSBH Ruqaih S. Alghsham, Shuchismita R. Satpathy, Sobha R. Bodduluri, Bindu ... Frontiers in Immunology 10, 2604, 2019 | 14 | 2019 |
| Vitamin E is a MIF Inhibitor B Hegde, P Vadnal, J Sanghavi, V Korde, AA Kulkarni-Almeida, ... Biochemical and Biophysical Research Communications 418 (2), 384-389, 2012 | 12 | 2012 |
| Considerations when treating high-grade pediatric glioma patients with immunotherapy E Crotty, K Downey, L Ferrerosa, C Flores, B Hegde, S Raskin, E Hwang, ... Expert review of neurotherapeutics 21 (2), 205-219, 2021 | 8 | 2021 |
| Enhancement of gut barrier function by microbial metabolite, urolithin A via AhR-Nrf2 dependent pathways in IBD VR Jala, R Singh, S Chandrashekarappa, SR Bodduluri, BV Becca, ... The Journal of Immunology 202 (1_Supplement), 192.4-192.4, 2019 | 3 | 2019 |
| A semi-synthetic natural product blocks collagen induced arthritis by preferentially suppressing the production of IL-6 A Kulkarni-Almeida, M Shah, M Jadhav, B Hegde, J Trivedi, PD Mishra, ... International Immunopharmacology 33, 63-69, 2016 | 2 | 2016 |
| Correspondence on'H3. 3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma'by Immisch et al ZS Chheda, S Mueller, B Hegde, A Yamamichi, LH Butterfield, H Okada Journal for Immunotherapy of Cancer 11 (3), 2023 | 1 | 2023 |
| Fusion of with at near-barrier energies VV Parkar, M Prasanna, R Rathod, V Jha, SK Pandit, A Shrivastava, ... Physical Review C 109 (1), 014610, 2024 | | 2024 |
| 403 Rapid and multiplexed identification of novel TCRs for TCR-T cell therapy T Moore, B Hegde, J Leonard, N Katz, A Sharathchandra, B Xie, J Dreux, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 1206 Discovery and preclinical pharmacology of bispecific antibodies targeting an HLA-A2 restricted tumor-associated antigen A Ramirez, N Guidotti, J Leonard, O Dalmas, J Kleiner, J Goldsmith, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| A functional approach to identifying and engineering TCRs results in highly-potent and specific TCRs for TCR-T cell therapy JD Leonard, A Ramirez, J Romero, J Kleiner, J Dreux, B Hegde, B Xie, ... Cancer Research 82 (12_Supplement), 578-578, 2022 | | 2022 |
| Neutron stripping cross sections in 7Li+205Tl system V Jha, A Shrivastava, K Mahata, K Ramachandran, A Parmar, R Palit, ... Proceedings of the DAE Symp. on Nucl. Phys 66, 381, 2022 | | 2022 |
| Engineering tertiary lymphoid structures for glioblastoma: A novel gene combination promotes therapeutic TLS formation in an immune-competent mouse model of GBM KM Downey, B Hegde, Z Chheda, J Zhang, H Okada Cancer Research 81 (13_Supplement), 74-74, 2021 | | 2021 |
| INDUCTION OF TERTIARY LYMPHOID STRUCTURE-LIKE T-CELL CLUSTERS BY DELIVERY OF A NOVEL GENE COMBINATION INTO AN IMMUNOCOMPETENT MOUSE MODEL OF GLIOBLASTOMA HO Kira Downey, Bindu Hegde, Zinal Chheda, Jason Zhang Neuro-Oncology 22, 2020 | | 2020 |
